Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.

Autor: Furtado RHM; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (R.H.M.F.).; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.).; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Raz I; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Goodrich EL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Bhatt DL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, ON, Canada (L.A.L.)., McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.)., Wilding JPH; Department of Cardiovascular and Metabolic Medicine, University of Liverpool, United Kingdom (J.P.H.W.)., Aylward P; South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide (P.A.)., Dalby AJ; Life Fourways Hospital, Randburg, Republic of South Africa (A.J.D.)., Dellborg M; Sahlgrenska Academy, University of Gothenburg, Sweden (M.D.)., Dimulescu D; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania (D.D.)., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.)., Oude Ophuis AJM; Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands (A.J.M.O.O.)., Cahn A; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Mosenzon O; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Gause-Nilsson I; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.)., Langkilde AM; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.)., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Wiviott SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).

Publikováno v: Circulation [Circulation] 2022 May 24; Vol. 145 (21), pp. 1581-1591. Date of Electronic Publication: 2022 May 05.

Patient-specific modelling of coronary hemodynamics: state of the art.

Autor: Singhal, Mudrika¹ (AUTHOR), Gupta, Raghvendra^1,2 (AUTHOR) guptar@iitg.ac.in

Publikováno v: Sādhanā: Academy Proceedings in Engineering Sciences. Dec2024, Vol. 49 Issue 4, p1-30. 30p.

Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.

Autor: Johnson, Linda S., Benz, Alexander P., Shoamanesh, Ashkan, Eikelboom, John W., Ezekowitz, Michael, Giugliano, Robert P., Wallentin, Lars, Ruff, Christian T., Lopes, Renato D., Jolly, Sanjit, Whitlock, Richard, Granger, Christopher B., Connolly, Stuart, Healey, Jeffrey S.

Publikováno v: Journal of the American Heart Association; 9/3/2024, Vol. 13 Issue 17, p1-11, 11p

Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin-K antagonists: A retrospective German claims data analysis.

Autor: Engelbertz C; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany., Marschall U; BARMER Institute for Health System Research, Wuppertal, Germany., Feld J; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany., Makowski L; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany., Lange SA; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany., Freisinger E; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany., Gerß J; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany., Breithardt G; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany., Faldum A; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany., Reinecke H; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany., Köppe J; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.

Publikováno v: Journal of internal medicine [J Intern Med] 2024 Oct; Vol. 296 (4), pp. 362-376. Date of Electronic Publication: 2024 Sep 02.

Recurrent spontaneous coronary artery dissection.

Autor: Xu, Minmin, Wang, Jian, Yuan, Kangzheng, Luo, Xiaoyan, Liu, Fangmei, Deng, Min, Wang, Daxin

Publikováno v: Coronary Artery Disease; Jan2023, Vol. 34 Issue 1, p59-65, 7p